DiagnaMed Holdings Corp DGNMF

Primary Symbol: C.DMED

Technology Software - Application

DiagnaMed Holdings Corp. is a Canada-based healthcare technology company focused on brain health using artificial intelligence (AI). The Company is commercializing BRAIN AGE Brain Health AI Platform, a consumer brain health and wellness AI solution that estimates brain age and provides a brain health score. The BRAIN AGE Brain Health AI Platform (BRAIN AGE) leverages its electroencephalograph (EEG) data from research studies and future data collection and applying it to build a potential drug discovery and clinical research AI platform. The BRAIN AGE estimates brain age by recording brain-wave activity from multiple brain regions and calculating the data with a proprietary machine-learning model. The BRAIN AGE has the potential to accelerate patient recruitment for clinical trials, data analysis, drug development go/no-go decisions and new treatment options for neurological, psychiatric and infectious diseases.

CSE:DMED - Post by User

DiagnaMed Holdings Corp

<< Previous

Bullboard Posts

Next >>

Post by Betteryear2on Mar 20, 2024 10:01am

99 Views

Post# 35942604

DiagnaMed BRAIN AGE® Trademark Registration Approved

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. (“DiagnaMed” or the “Company”) (CSE: DMED) (OTCQB: DGNMF), an artificial intelligence digital healthcare company, announced its application for registration for trademark on its BRAIN AGE® brand has been approved by the Canadian Intellectual Property Office (CIPO), particularly for commercial use throughout Canada for the goods and services for which it is registered as a neurological monitoring apparatus, electroencephalogram-based apparatus, and brain monitoring apparatus.

DiagnaMed Announces BRAIN AGE® Trademark Registration (globenewswire.com)

<< Previous

Bullboard Posts

Next >>

Crypto and blockchain stock ends year with a profit